Tom Winnifrith Bearcast: an unpriced option to buy 80% of a business with no given profits at no specified cost is worth what?
James Fisher & Sons – “the board remains confident in the group's strategy”. Er, why the “detailed” reviews then?!
Of course there is no insider dealing in London and on AIM - just look at the Vast Resources 5 day chart
Rutherford Health (Formerly Proton Partners) – Delays, Delays From Former Neil Woodford Favourite. Has the Cash Run Out Yet?
Today we are told via RNS Reach “New Briefing Note from SEAL” on MyHealthChecked (MHC). Sadly it is SEAL Research not Seal the popular singer, otherwise known as Henry Olusegun Adeola Samuel, or a whiskered fellow from London zoo as both of the would have more credibility than the paid for rampers taking centre stage today. It is SEAL that has issued the release and this is another big sell signal for MyHealthChecked. It is a red flag and I am glad to be out.
Events have moved apace since this appeared.These shares are not a buy as explained HERE. MyHealthchecked (MHC) has flagged up what we loyal shareholders can all expect to hear about over the next month or so. First up on September 29 when we will get the interim results to June 30 and a Q3 trading update.
MyHealthChecked (MHC) has made an RNS announcement including that it is “delighted” to now have in place accreditation across its COVID-19 testing service. How delighted should it be with recent developments?
Earlier today, I broke the news that MyHealthChecked (MHC) where I am, of course, a loyal shareholder is now selling its covid tests via Lloyds Pharmacies. We do not know if it is just online or in any or all of the company’s 1400 stores but this is clearly material. MyHealthchecked has announced nothing. At one point earlier, the shares were up 38%. My job as a journalist is to break news which I did. I will not trade any shares until the company comes clean and probably not even then. The company’s duties under AIM listing rules include maintaining an orderly market in its shares. It has failed in that. I have written to the Oxymorons at AIM Regulation demanding an enquiry and a statement.
This is massive. Lloyds has 1400 stores across the UK. And as you can see HERE, it is now selling the MyHealthChecked (MHC) covid test. Boots is selling the test from more than 500 stores and that deal plus sales from MyHealthChecked's own portal managed to drive sales of c£3 million in May and June alone. So gaining this additional distribution (plus that from partnering with EasyJet) is surely highly material. Why no RNS?
MyHealthChecked (MHC) has welcomed a UK government announcement that COVID-19 testing companies will be removed from the approved list if they advertise misleading prices, emphasising that it provides “clear, transparent and market competitive pricing… also ensures a high standard of service and robust laboratory capacity planning methods to ensure customer needs are met”.
MyHealthChecked (MHC) has made a trading update, emphasising “the first half of 2021 has seen a transformation of our business” and the shares have responded more than 7% higher to 3.8p – so what’s the transformation?
MyHealthChecked (MHC) has announced an acquisition which it emphasises represents expansion which sits well alongside its home-administered postal genomic testing services and currently its COVID-19 sample collection kit and service.
MyHealthChecked (MHC) has announced results for the 2020 calendar year and that “the impact of our COVID testing business is expected to have a material impact on the company's performance in 2021”, whilst also “a strong pipeline outside of COVID-19 building, life after COVID is exciting, and we enter this phase with growing confidence in the road to delivery”. That sounds encouraging.
MyHealthChecked (MHC) has announced it has “signed a manufacturing agreement and placed a further purchase order of £1.425m with EKF Diagnostic Holdings plc (EKF) for PrimeStore® MTM sample collection devices”. This looks a potentially significant indicator.
There are no numbers in a latest RNS from MyHealthChecked (MHC) but those close to the company talk of numbers for this year which are off the wall. As such you would currently be insane to sell – when the market twigs these shares will surge well past 10p...
This is good news for we loyal shareholders but not the great news. That, I now expect, is to be announced early next week.
My suggestion, made to AIM Regulation and HERE, that shares in all covid testing stocks be suspended on Monday seems to have aroused every idiot who has ever bought an AIM listed share into outrage and anger. Brokerman Dan has joined this populist outrage.
Yes, even MyHealthChecked (MHC) where I am a shareholder should have its shares suspended. The reason is a webpage which went live yesterday and which is now being widely discussed on social media which seems to show that the Government is soon to announce contracts worth £8 billion for covid test suppliers. This is going to cause share price mayhem on Monday.
Reader SB asks if there are any forecasts for MyHealthChecked (MHC). There are not. Not even from the UK’s leading healthcare analyst Mr Brokerman Dan Levi. However, the company does give indications of what sort of sales it might achieve in a corporate presentation video below. There is more and I am not sure what this means and think MyHealthChecked should clarify.
Last year, we discovered on Friday that MyHealthChecked (MHC) lost £2.5 million on sales of £50,000. Yes that is dreadful but this company is now about the future of its Covid and other DNA tests and thus it has raised £3.4 million at 1.75p. It was not completely out of cash so, after costs, it probably has c£3.5 million in the bank.
Concepta has announced a change of name to MyHealthChecked (MHC) and, more interestingly, jumped on board the Covid testing bandwagon. I am, as you know, a sceptic on many things relating to a disease where 99.95% of those under 70 recover and where the average age of death is, at 82, one year more than UK life expectancy. However...
Search ShareProphets |
Recent Comments |